APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Generic Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Animal Generic Drug Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchAnimal Generic Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Generic Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Animal Generic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Generic Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Generic Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Animal Generic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Animal Generic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Animal Generic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Generic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Animal Generic Drug include Zoetis, Merck, Bayer Animal Health, Vetoquinol, Perrigo, Norbrook, Huvepharma, Elanco and Ceva Sante Animale, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Animal Generic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Animal Generic Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Animal Generic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Animal Generic Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Animal Generic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Animal Generic Drug Market by Company

Zoetis

Merck

Bayer Animal Health

Vetoquinol

Perrigo

Norbrook

Huvepharma

Elanco

Ceva Sante Animale

Boehringer Ingelheim

Bimeda

Animal Generic Drug Segment by Type

Pharmaceuticals

Medicinal Feed Additives

Biologicals

Animal Generic Drug Segment by Application

Cows

Broilers

Pigs

Others

Animal Generic Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Generic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Generic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Generic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Animal Generic Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Animal Generic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pharmaceuticals Table 2. Major Company of Medicinal Feed Additives Table 3. Major Company of Biologicals Table 4. Global Animal Generic Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Animal Generic Drug Sales by Type (2021-2026) & (k units) Table 6. Global Animal Generic Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Animal Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Animal Generic Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Animal Generic Drug Price by Type (2021-2026) & (US$/unit) Table 10. Global Animal Generic Drug Sales by Type (2027-2032) & (k units) Table 11. Global Animal Generic Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Animal Generic Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Animal Generic Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Animal Generic Drug Price by Type (2027-2032) & (US$/unit) Table 15. North America Animal Generic Drug Sales by Type (2021-2026) & (k units) Table 16. North America Animal Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Animal Generic Drug Sales by Type (2021-2026) & (k units) Table 18. Europe Animal Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Animal Generic Drug Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Animal Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Animal Generic Drug Sales by Type (2021-2026) & (k units) Table 22. Latin America Animal Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Animal Generic Drug Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Animal Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Animal Generic Drug Industry Trends Table 26. Animal Generic Drug Industry Drivers Table 27. Animal Generic Drug Industry Opportunities and Challenges Table 28. Animal Generic Drug Industry Restraints Table 29. Global Animal Generic Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Animal Generic Drug Revenue Market Share by Company (2021-2026) Table 31. Global Animal Generic Drug Sales by Company (2021-2026) & (k units) Table 32. Global Animal Generic Drug Sales Share by Company (2021-2026) Table 33. Global Animal Generic Drug Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Animal Generic Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Animal Generic Drug Major Company Production Sites and Headquarters Table 36. Global Animal Generic Drug Company, Product Type & Application Table 37. Global Animal Generic Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Animal Generic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Animal Generic Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Animal Generic Drug Sales by Region (2021-2026) & (k units) Table 42. Global Animal Generic Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Animal Generic Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Animal Generic Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Animal Generic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Animal Generic Drug Sales by Region (2027-2032) & (k units) Table 47. Global Animal Generic Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Animal Generic Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Animal Generic Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Animal Generic Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Animal Generic Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Animal Generic Drug Sales by Application (2021-2026) & (k units) Table 53. Global Animal Generic Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Animal Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Animal Generic Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Animal Generic Drug Price by Application (2021-2026) & (US$/unit) Table 57. Global Animal Generic Drug Sales by Application (2027-2032) & (k units) Table 58. Global Animal Generic Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Animal Generic Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Animal Generic Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Animal Generic Drug Price by Application (2027-2032) & (US$/unit) Table 62. North America Animal Generic Drug Sales by Application (2021-2026) & (k units) Table 63. North America Animal Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Animal Generic Drug Sales by Application (2021-2026) & (k units) Table 65. Europe Animal Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Animal Generic Drug Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Animal Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Animal Generic Drug Sales by Application (2021-2026) & (k units) Table 69. Latin America Animal Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Animal Generic Drug Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Animal Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Zoetis Company Information Table 73. Zoetis Business Overview Table 74. Zoetis Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Zoetis Animal Generic Drug Product Portfolio Table 76. Zoetis Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Merck Animal Generic Drug Product Portfolio Table 81. Merck Recent Development Table 82. Bayer Animal Health Company Information Table 83. Bayer Animal Health Business Overview Table 84. Bayer Animal Health Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Bayer Animal Health Animal Generic Drug Product Portfolio Table 86. Bayer Animal Health Recent Development Table 87. Vetoquinol Company Information Table 88. Vetoquinol Business Overview Table 89. Vetoquinol Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Vetoquinol Animal Generic Drug Product Portfolio Table 91. Vetoquinol Recent Development Table 92. Perrigo Company Information Table 93. Perrigo Business Overview Table 94. Perrigo Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Perrigo Animal Generic Drug Product Portfolio Table 96. Perrigo Recent Development Table 97. Norbrook Company Information Table 98. Norbrook Business Overview Table 99. Norbrook Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Norbrook Animal Generic Drug Product Portfolio Table 101. Norbrook Recent Development Table 102. Huvepharma Company Information Table 103. Huvepharma Business Overview Table 104. Huvepharma Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Huvepharma Animal Generic Drug Product Portfolio Table 106. Huvepharma Recent Development Table 107. Elanco Company Information Table 108. Elanco Business Overview Table 109. Elanco Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Elanco Animal Generic Drug Product Portfolio Table 111. Elanco Recent Development Table 112. Ceva Sante Animale Company Information Table 113. Ceva Sante Animale Business Overview Table 114. Ceva Sante Animale Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Ceva Sante Animale Animal Generic Drug Product Portfolio Table 116. Ceva Sante Animale Recent Development Table 117. Boehringer Ingelheim Company Information Table 118. Boehringer Ingelheim Business Overview Table 119. Boehringer Ingelheim Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Boehringer Ingelheim Animal Generic Drug Product Portfolio Table 121. Boehringer Ingelheim Recent Development Table 122. Bimeda Company Information Table 123. Bimeda Business Overview Table 124. Bimeda Animal Generic Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Bimeda Animal Generic Drug Product Portfolio Table 126. Bimeda Recent Development Table 127. North America Animal Generic Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. North America Animal Generic Drug Sales by Country (2021-2026) & (k units) Table 129. North America Animal Generic Drug Sales Market Share by Country (2021-2026) Table 130. North America Animal Generic Drug Sales Forecast by Country (2027-2032) & (k units) Table 131. North America Animal Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 132. North America Animal Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Animal Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Animal Generic Drug Market Share by Country (2021-2026) Table 135. North America Animal Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Animal Generic Drug Market Share Forecast by Country (2027-2032) Table 137. Europe Animal Generic Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Europe Animal Generic Drug Sales by Country (2021-2026) & (k units) Table 139. Europe Animal Generic Drug Sales Market Share by Country (2021-2026) Table 140. Europe Animal Generic Drug Sales Forecast by Country (2027-2032) & (k units) Table 141. Europe Animal Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Animal Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Animal Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Animal Generic Drug Market Share by Country (2021-2026) Table 145. Europe Animal Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Animal Generic Drug Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Animal Generic Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Animal Generic Drug Sales by Country (2021-2026) & (k units) Table 149. Asia-Pacific Animal Generic Drug Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Animal Generic Drug Sales Forecast by Country (2027-2032) & (k units) Table 151. Asia-Pacific Animal Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Animal Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Animal Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Animal Generic Drug Market Share by Country (2021-2026) Table 155. Asia-Pacific Animal Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Animal Generic Drug Market Share Forecast by Country (2027-2032) Table 157. Latin America Animal Generic Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Latin America Animal Generic Drug Sales by Country (2021-2026) & (k units) Table 159. Latin America Animal Generic Drug Sales Market Share by Country (2021-2026) Table 160. Latin America Animal Generic Drug Sales Forecast by Country (2027-2032) & (k units) Table 161. Latin America Animal Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Animal Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Animal Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Animal Generic Drug Market Share by Country (2021-2026) Table 165. Latin America Animal Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Animal Generic Drug Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Animal Generic Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Animal Generic Drug Sales by Country (2021-2026) & (k units) Table 169. Middle East and Africa Animal Generic Drug Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Animal Generic Drug Sales Forecast by Country (2027-2032) & (k units) Table 171. Middle East and Africa Animal Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Animal Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Animal Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Animal Generic Drug Market Share by Country (2021-2026) Table 175. Middle East and Africa Animal Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Animal Generic Drug Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Animal Generic Drug Distributors List Table 180. Animal Generic Drug Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Animal Generic Drug Image Figure 2. Global Animal Generic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Generic Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal Generic Drug Sales (2021-2032) & (k units) Figure 5. Pharmaceuticals Image Figure 6. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (k units) Figure 7. Medicinal Feed Additives Image Figure 8. Global Medicinal Feed Additives Sales YoY Growth (2021-2032) & (k units) Figure 9. Biologicals Image Figure 10. Global Biologicals Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Animal Generic Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Animal Generic Drug Market Share by Type 2025 VS 2032 Figure 13. North America Animal Generic Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Animal Generic Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Animal Generic Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Animal Generic Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Animal Generic Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Animal Generic Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Animal Generic Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Animal Generic Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Animal Generic Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Animal Generic Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Animal Generic Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cows Image Figure 26. Global Cows Sales YoY Growth (2021-2032) & (k units) Figure 27. Broilers Image Figure 28. Global Broilers Sales YoY Growth (2021-2032) & (k units) Figure 29. Pigs Image Figure 30. Global Pigs Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Animal Generic Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Animal Generic Drug Market Share by Application 2025 VS 2032 Figure 35. North America Animal Generic Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Animal Generic Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Animal Generic Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Animal Generic Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Animal Generic Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Animal Generic Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Animal Generic Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Animal Generic Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Animal Generic Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Animal Generic Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Animal Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Animal Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Animal Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Animal Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Animal Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Animal Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Animal Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Animal Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Animal Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Animal Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Animal Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Animal Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Animal Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Animal Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Animal Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Animal Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Animal Generic Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Animal Generic Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Biologicals
Applications
  • Cows
  • Broilers
  • Pigs
  • Others
Companies covered
  • Zoetis
  • Merck
  • Bayer Animal Health
  • Vetoquinol
  • Perrigo
  • Norbrook
  • Huvepharma
  • Elanco
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Bimeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal Generic Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Animal Generic Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Animal Generic Drug Market by Type
  6. 1.3.1 Pharmaceuticals
  7. 1.3.2 Medicinal Feed Additives
  8. 1.3.3 Biologicals
  9. 1.4 Global Animal Generic Drug Market Size by Type
  10. 1.4.1 Global Animal Generic Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Animal Generic Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Animal Generic Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Animal Generic Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Animal Generic Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Animal Generic Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Animal Generic Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Animal Generic Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Animal Generic Drug Industry Trends
  2. 2.2 Animal Generic Drug Industry Drivers
  3. 2.3 Animal Generic Drug Industry Opportunities and Challenges
  4. 2.4 Animal Generic Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Animal Generic Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Animal Generic Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Animal Generic Drug Price (2021-2026)
  4. 3.4 Global Animal Generic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Animal Generic Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Animal Generic Drug Company, Product Type & Application
  7. 3.7 Global Animal Generic Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Animal Generic Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Animal Generic Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Animal Generic Drug Tier 1, Tier 2, and Tier 3
4 Animal Generic Drug Regional Status and Outlook
  1. 4.1 Global Animal Generic Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Animal Generic Drug Historic Market Size by Region
  3. 4.2.1 Global Animal Generic Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Animal Generic Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Animal Generic Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Animal Generic Drug Forecasted Market Size by Region
  7. 4.3.1 Global Animal Generic Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Animal Generic Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Animal Generic Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Animal Generic Drug by Application
  1. 5.1 Animal Generic Drug Market by Application
  2. 5.1.1 Cows
  3. 5.1.2 Broilers
  4. 5.1.3 Pigs
  5. 5.1.4 Others
  6. 5.2 Global Animal Generic Drug Market Size by Application
  7. 5.2.1 Global Animal Generic Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Animal Generic Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Animal Generic Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Animal Generic Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Animal Generic Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Animal Generic Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Animal Generic Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Animal Generic Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Animal Generic Drug Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Animal Generic Drug Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Bayer Animal Health
  14. 6.3.1 Bayer Animal Health Company Information
  15. 6.3.2 Bayer Animal Health Business Overview
  16. 6.3.3 Bayer Animal Health Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Animal Health Animal Generic Drug Product Portfolio
  18. 6.3.5 Bayer Animal Health Recent Developments
  19. 6.4 Vetoquinol
  20. 6.4.1 Vetoquinol Company Information
  21. 6.4.2 Vetoquinol Business Overview
  22. 6.4.3 Vetoquinol Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Vetoquinol Animal Generic Drug Product Portfolio
  24. 6.4.5 Vetoquinol Recent Developments
  25. 6.5 Perrigo
  26. 6.5.1 Perrigo Company Information
  27. 6.5.2 Perrigo Business Overview
  28. 6.5.3 Perrigo Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Perrigo Animal Generic Drug Product Portfolio
  30. 6.5.5 Perrigo Recent Developments
  31. 6.6 Norbrook
  32. 6.6.1 Norbrook Company Information
  33. 6.6.2 Norbrook Business Overview
  34. 6.6.3 Norbrook Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Norbrook Animal Generic Drug Product Portfolio
  36. 6.6.5 Norbrook Recent Developments
  37. 6.7 Huvepharma
  38. 6.7.1 Huvepharma Company Information
  39. 6.7.2 Huvepharma Business Overview
  40. 6.7.3 Huvepharma Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Huvepharma Animal Generic Drug Product Portfolio
  42. 6.7.5 Huvepharma Recent Developments
  43. 6.8 Elanco
  44. 6.8.1 Elanco Company Information
  45. 6.8.2 Elanco Business Overview
  46. 6.8.3 Elanco Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Elanco Animal Generic Drug Product Portfolio
  48. 6.8.5 Elanco Recent Developments
  49. 6.9 Ceva Sante Animale
  50. 6.9.1 Ceva Sante Animale Company Information
  51. 6.9.2 Ceva Sante Animale Business Overview
  52. 6.9.3 Ceva Sante Animale Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ceva Sante Animale Animal Generic Drug Product Portfolio
  54. 6.9.5 Ceva Sante Animale Recent Developments
  55. 6.10 Boehringer Ingelheim
  56. 6.10.1 Boehringer Ingelheim Company Information
  57. 6.10.2 Boehringer Ingelheim Business Overview
  58. 6.10.3 Boehringer Ingelheim Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boehringer Ingelheim Animal Generic Drug Product Portfolio
  60. 6.10.5 Boehringer Ingelheim Recent Developments
  61. 6.11 Bimeda
  62. 6.11.1 Bimeda Company Information
  63. 6.11.2 Bimeda Business Overview
  64. 6.11.3 Bimeda Animal Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bimeda Animal Generic Drug Product Portfolio
  66. 6.11.5 Bimeda Recent Developments
7 North America by Country
  1. 7.1 North America Animal Generic Drug Sales by Country
  2. 7.1.1 North America Animal Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Animal Generic Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Animal Generic Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Animal Generic Drug Market Size by Country
  6. 7.2.1 North America Animal Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Animal Generic Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Animal Generic Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Animal Generic Drug Sales by Country
  2. 8.1.1 Europe Animal Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Animal Generic Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Animal Generic Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Animal Generic Drug Market Size by Country
  6. 8.2.1 Europe Animal Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Animal Generic Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Animal Generic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Animal Generic Drug Sales by Country
  2. 9.1.1 Asia-Pacific Animal Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Animal Generic Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Animal Generic Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Animal Generic Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Animal Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Animal Generic Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Animal Generic Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Animal Generic Drug Sales by Country
  2. 10.1.1 South America Animal Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Animal Generic Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Animal Generic Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Animal Generic Drug Market Size by Country
  6. 10.2.1 South America Animal Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Animal Generic Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Animal Generic Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Animal Generic Drug Sales by Country
  2. 11.1.1 Middle East and Africa Animal Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Animal Generic Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Animal Generic Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Animal Generic Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Animal Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Animal Generic Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Animal Generic Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Animal Generic Drug Value Chain Analysis
  2. 12.1.1 Animal Generic Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Animal Generic Drug Production Mode & Process
  7. 12.2 Animal Generic Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Animal Generic Drug Distributors
  10. 12.2.3 Animal Generic Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst